Arcutis Biotherapeutics Clinical Site 22 — Plainfield, Indiana

Arcutis Biotherapeutics Clinical Site 22 is a clinical research site located in Plainfield, Indiana, United States 46168.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Arcutis Biotherapeutics Clinical Site 22 has participated in 3 clinical trials.

Therapeutic areas: Seborrheic Dermatitis.

Sponsors: Arcutis Biotherapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Plainfield

Browse all research sites in Indiana · View every site in Plainfield

• The Indiana Clinical Trials Center
• The Indiana Clinical Trials Center PC
• Indiana Clinical Trial Center
• Indiana Clinical Trials Center
• Dermavant Investigative Site
• Regeneron Investigational Site
• Investigator Site
• Vanda Investigational Site
• Dermatology Center of Indiana/Indiana Clinical Trials Center
• Fougera Investigational Site
• Aclaris Investigational Site

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Arcutis Biotherapeutics Clinical Site 22?

Arcutis Biotherapeutics Clinical Site 22 has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Arcutis Biotherapeutics Clinical Site 22 conducted?

Arcutis Biotherapeutics Clinical Site 22 has 3 clinical trials on record. Their work covers Seborrheic Dermatitis.

Is Arcutis Biotherapeutics Clinical Site 22 accredited by Crixeo Clinical Trials?

Arcutis Biotherapeutics Clinical Site 22 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Arcutis Biotherapeutics Clinical Site 22?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.